HIV-1 Vif: counteracting innate antiretroviral defenses (Q44621773)

From Wikidata

Revision as of 04:33, 14 December 2023 by KrBot (talk | contribs) (‎Set a claim value: title (P1476): HIV-1 Vif: counteracting innate antiretroviral defenses)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published in October 2003

Language	Label	Description	Also known as
English	HIV-1 Vif: counteracting innate antiretroviral defenses	scientific article published in October 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

HIV-1 Vif: counteracting innate antiretroviral defenses (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Bryan R Cullen

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Molecular Therapy

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

525-527

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.08.010

7 January 2021

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.08.010

7 January 2021

DNA deamination mediates innate immunity to retroviral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.08.010

7 January 2021

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.08.010

7 January 2021

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.08.010

7 January 2021

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.08.010

7 January 2021

Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.08.010

7 January 2021

Evidence for a newly discovered cellular anti-HIV-1 phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.08.010

7 January 2021

The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.08.010

7 January 2021

Restriction factors: a defense against retroviral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.08.010

7 January 2021

Identifiers

10.1016/J.YMTHE.2003.08.010

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44621773&oldid=2029547245"